Ischemic stroke remains a vexing public health problem. Although progress has been made in prevention and supportive care, efforts to protect the brain from ischemic cell death have failed. Thus, no new treatment has made it from bench to bedside since tissue plasminogen activator was introduced in 1996. The brain has a remarkable capacity for self-preservation, illustrated by the protective responses induced by ischemia, preconditioning and exercise. Here we describe the mechanisms underlying brain self-protection, with the goal of identifying features that could provide insight into stroke therapy. Unlike traditional therapeutic approaches based on counteracting selected pathways of the ischemic cascade, endogenous neuroprotection relies on coordinated neurovascular programs that support cerebral perfusion, mitigate the harmful effects of cerebral ischemia and promote tissue restoration. Learning how the brain triggers and implements these protective measures may advance our quest to treat stroke.
Subscribe to Journal
Get full journal access for 1 year
only $18.75 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Roger, V.L. et al. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation 123, e18–e209 (2011).
Hachinski, V. et al. Stroke: working toward a prioritized world agenda. Stroke 41, 1084–1099 (2010).
Fonarow, G.C. et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation 123, 750–758 (2011).
Moskowitz, M.A., Lo, E.H. & Iadecola, C. The science of stroke: mechanisms in search of treatments. Neuron 67, 181–198 (2010).
Moskowitz, M.A. Brain protection: maybe yes, maybe no. Stroke 41, S85–S86 (2010).
Kunz, A. & Iadecola, C. Cerebral vascular dysregulation in the ischemic brain. in Handbook of Clinical Neurology Vol. 92, Ch. 14, (eds. Vinken, P.J. and Bruyn, G.W.) 92, Ch. 14, 283–305 (2008).
Iadecola, C. & Anrather, J. The immunology of stroke: from mechanisms to translation. Nat. Med. 17, 796–808 (2011).
Johansson, A., Ahrén, B., Näsman, B., Carlström, K. & Olsson, T. Cortisol axis abnormalities early after stroke—relationships to cytokines and leptin. J. Intern. Med. 247, 179–187 (2000).
Liebeskind, D.S. Reperfusion for acute ischemic stroke: arterial revascularization and collateral therapeutics. Curr. Opin. Neurol. 23, 36–45 (2010).
Sharp, F.R., Bergeron, M. & Bernaudin, M. Hypoxia-inducible factor in brain. Adv. Exp. Med. Biol. 502, 273–291 (2001).
Dirnagl, U., Simon, R.P. & Hallenbeck, J.M. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 26, 248–254 (2003).
Paschen, W. Shutdown of translation: lethal or protective? Unfolded protein response versus apoptosis. J. Cereb. Blood Flow Metab. 23, 773–779 (2003).
Hardingham, G.E. & Lipton, S.A. Regulation of neuronal oxidative and nitrosative stress by endogenous protective pathways and disease processes. Antioxid. Redox Signal. 14, 1421–1424 (2011).
Yenari, M.A. Heat shock proteins and neuroprotection. Adv. Exp. Med. Biol. 513, 281–299 (2002).
Greenberg, D.A. & Jin, K. Growth factors and stroke. NeuroRx 3, 458–465 (2006).
Torres-Aleman, I. Toward a comprehensive neurobiology of IGF-I. Dev. Neurobiol. 70, 384–396 (2010).
Digicaylioglu, M. Erythropoietin in stroke: quo vadis. Expert Opin. Biol. Ther. 10, 937–949 (2010).
Kitagawa, K. CREB and cAMP response element-mediated gene expression in the ischemic brain. FEBS J. 274, 3210–3217 (2007).
Clarkson, A.N., Huang, B.S., Macisaac, S.E., Mody, I. & Carmichael, S.T. Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature 468, 305–309 (2010).
Kernie, S.G. & Parent, J.M. Forebrain neurogenesis after focal ischemic and traumatic brain injury. Neurobiol. Dis. 37, 267–274 (2010).
Zhang, Z.G., Zhang, L., Jiang, Q. & Chopp, M. Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ. Res. 90, 284–288 (2002).
Dirnagl, U., Becker, K. & Meisel, A. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol. 8, 398–412 (2009).
Saxena, P., Newman, M.A.J., Shehatha, J.S., Redington, A.N. & Konstantinov, I.E. Remote ischemic conditioning: evolution of the concept, mechanisms, and clinical application. J. Card. Surg. 25, 127–134 (2010).
Kunz, A. et al. Neurovascular protection by ischemic tolerance: role of nitric oxide and reactive oxygen species. J. Neurosci. 27, 7083–7093 (2007).
Pedersen, C.M. et al. Remote ischemic preconditioning prevents systemic platelet activation associated with ischemia-reperfusion injury in humans. J. Thromb. Haemost. 9, 404–407 (2011).
Zhang, Y., Park, T.S. & Gidday, J.M. Hypoxic preconditioning protects human brain endothelium from ischemic apoptosis by Akt-dependent survivin activation. Am. J. Physiol. Heart Circ. Physiol. 292, H2573–H2581 (2007).
Gesuete, R. et al. Glial cells drive preconditioning-induced blood-brain barrier protection. Stroke 42, 1445–1453 (2011).
Andjelkovic, A.V., Stamatovic, S.M. & Keep, R.F. The protective effects of preconditioning on cerebral endothelial cells in vitro. J. Cereb. Blood Flow Metab. 23, 1348–1355 (2003).
Huang, S.S., Wei, F.C. & Hung, L.M. Ischemic preconditioning attenuates postischemic leukocyte–endothelial cell interactions: role of nitric oxide and protein kinase C. Circ. J. 70, 1070–1075 (2006).
Cotman, C.W., Berchtold, N.C. & Christie, L.-A. Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci. 30, 464–472 (2007).
Endres, M. et al. Mechanisms of stroke protection by physical activity. Ann. Neurol. 54, 582–590 (2003).
Llorens-Martín, M., Torres-Alemán, I. & Trejo, J.L. Exercise modulates insulin-like growth factor 1-dependent and -independent effects on adult hippocampal neurogenesis and behaviour. Mol. Cell. Neurosci. 44, 109–117 (2010).
Gómez-Pinilla, F., Dao, L. & So, V. Physical exercise induces FGF-2 and its mRNA in the hippocampus. Brain Res. 764, 1–8 (1997).
Zaheer, A. et al. GMF-knockout mice are unable to induce brain-derived neurotrophic factor after exercise. Neurochem. Res. 31, 579–584 (2006).
Zhang, F., Wu, Y. & Jia, J. Exercise preconditioning and brain ischemic tolerance. Neuroscience 177, 170–176 (2011).
Dishman, R.K. et al. Neurobiology of exercise. Obesity (Silver Spring) 14, 345–356 (2006).
Pedersen, B.K. & Febbraio, M.A. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol. Rev. 88, 1379–1406 (2008).
Rasmussen, P. et al. Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp. Physiol. 94, 1062–1069 (2009).
Fagan, S., Cronic, L.E. & Hess, D.C. Minocycline development for acute ischemic stroke. Transl. Stroke Res. 2, 202–208 (2011).
Bath, P.M. & Sprigg, N. Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke. Cochrane Database of Systematic Reviews CD005207, published online, doi:10.1002/14651858.CD005207.pub3 (2007).
Ehrenreich, H. et al. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 40, e647–e656 (2009).
Tang, X.N. & Yenari, M.A. Hypothermia as a cytoprotective strategy in ischemic tissue injury. Ageing Res. Rev. 9, 61–68 (2010).
Hemmen, T.M. et al. Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L): final results. Stroke 41, 2265–2270 (2010).
Koch, S., Katsnelson, M., Dong, C. & Perez-Pinzon, M. Remote ischemic limb preconditioning after subarachnoid hemorrhage: a phase Ib study of safety and feasibility. Stroke 42, 1387–1391 (2011).
Ren, C. et al. Limb remote ischemic postconditioning protects against focal ischemia in rats. Brain Res. 1288, 88–94 (2009).
Dreixler, J.C. et al. Delayed post-ischemic conditioning significantly improves the outcome after retinal ischemia. Exp. Eye Res. 92, 521–527 (2011).
Stapels, M. et al. Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance. Sci. Signal. 3, ra15 (2010).
Morris, K.C., Lin, H.W., Thompson, J.W. & Perez-Pinzon, M.A. Pathways for ischemic cytoprotection: Role of sirtuins in caloric restriction, resveratrol, and ischemic preconditioning. J. Cereb. Blood Flow Metab. 31, 1003–1019 (2011).
Stenzel-Poore, M.P. et al. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet 362, 1028–1037 (2003).
Marsh, B. et al. Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3. J. Neurosci. 29, 9839–9849 (2009).
This work was supported by US National Institutes of Health grants R37-NS34179 and NS35806.
The authors declare no competing financial interests.
About this article
Cite this article
Iadecola, C., Anrather, J. Stroke research at a crossroad: asking the brain for directions. Nat Neurosci 14, 1363–1368 (2011). https://doi.org/10.1038/nn.2953
Endothelium-targeted deletion of the miR-15a/16-1 cluster ameliorates blood-brain barrier dysfunction in ischemic stroke
Science Signaling (2020)
Transient Forebrain Ischemia Induces Differential Bdnf Transcript Expression and Histone Acetylation Patterns in the Rat Hippocampus
Journal of Molecular Neuroscience (2020)
Exosomes from human urine‐derived stem cells enhanced neurogenesis via miR‐26a/HDAC6 axis after ischaemic stroke
Journal of Cellular and Molecular Medicine (2020)
Metabolic Brain Disease (2020)
A network pharmacology approach to investigate the mechanism of Shuxuening injection in the treatment of ischemic stroke
Journal of Ethnopharmacology (2020)